Skip to main content
OpenTrials

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,230 public trials 3,233 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Active, Not Recruiting

IMPROVE: Circulating Tumor DNA Analysis to Optimize Treatment for Patients With Colorectal Cancer

NCT03637686

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • Aalborg University Hospital Aalborg, North Denmark, Denmark
  • Odense University Hospital Odense, The Region of Southern Denmark, Denmark
  • Aarhus University Hospital Aarhus, Denmark
  • Bispebjerg Hospital Copenhagen, Denmark
View Trial Details
Active, Not Recruiting

Rectal Cancer And Pre-operative Induction Therapy Followed by Dedicated Operation. The RAPIDO Trial

NCT01558921

Conditions
Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations
  • Siteman Cancer Center, Washington University Medical School St Louis, Missouri, United States
  • Aalborg Universitetshospital Aalborg, Denmark
  • Odense Universitetshospital Odense, Denmark
  • University Medical Center Groningen Groningen, PO BOX 30001, Netherlands
View all 56 locations
View Trial Details
Active, Not Recruiting

mPATH-Cloud for Colorectal Cancer Screening

NCT06441487

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • Lineberger Comphrehensive Cancer Center at University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • Wake Forest University Winston-Salem, North Carolina, United States
View Trial Details
Active, Not Recruiting

Durvalumab and Tremelimumab as First Line Treatment in Participants With Advanced Hepatocellular Carcinoma (HCC)

NCT05883644

Conditions
Advanced Hepatocellular Carcinoma, Digestive System Diseases, Digestive System Neoplasms, +4 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Shreveport, Louisiana, United States
  • Research Site Detroit, Michigan, United States
  • Research Site Bobigny, France
View all 40 locations
View Trial Details
Active, Not Recruiting

A Study of TACE Combined With Atezolizumab Plus Bevacizumab or TACE Alone in Patients With Untreated Heaptocellular Carcionma

NCT04712643

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Anhui Provincial Hospital Anhui, China
  • Peking University First Hospital Beijing, China
  • Peking University People's Hospital Beijing, China
  • Beijing You An Hospital Beijing, China
View all 40 locations
View Trial Details

Related conditions